Since these changes without additional findings may point to either biologically indolent tumor areas or limitations of the testing panel, the presence of an isolated APC truncating mutation in an apparently malignant tumor sample cannot be treated as a definitive molecular marker confirming the presence of CRC. The gene discussed is APC; the disease is neoplasm.